These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A case series of atypical presentations of thrombotic thrombocytopenic purpura. Imanirad I; Rajasekhar A; Zumberg M J Clin Apher; 2012; 27(4):221-6. PubMed ID: 22467376 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Hull MJ; Eichbaum QG Clin Adv Hematol Oncol; 2006 Mar; 4(3):210-4; discussion 217-8. PubMed ID: 16728930 [No Abstract] [Full Text] [Related]
31. Fulminant thrombotic thrombocytopenic purpura in a patient with the limited form of scleroderma: successful outcome using plasma exchange. Cookson S; Krueger ML; Bennett RM J Rheumatol; 1991 Jun; 18(6):900-1. PubMed ID: 1895272 [TBL] [Abstract][Full Text] [Related]
32. Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura. Scaramucci L; Niscola P; Palumbo R; Giovannini M; Ales M; Tendas A; Cupelli L; Natale G; Dentamaro T; Perrotti AP; de Fabritiis P Int J Hematol; 2009 Apr; 89(3):398-399. PubMed ID: 19294484 [No Abstract] [Full Text] [Related]
34. A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer. Lee JL; Lee JH; Kim MK; Cho HS; Bae YK; Cho KH; Bae SH; Ryoo HM; Lee KH; Hyun MS Jpn J Clin Oncol; 2004 Aug; 34(8):476-80. PubMed ID: 15371467 [TBL] [Abstract][Full Text] [Related]
35. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP. Bayraktar S; Eileen B; Shariatmadar S; Lian E BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444 [TBL] [Abstract][Full Text] [Related]
36. Thrombotic thrombocytopenic purpura complicating immune thrombocytopenic purpura--a case report. Changela A; Jagarlamudi K; Villani G; Alhuwalia M; Elnawawi A Am J Hematol; 2011 Apr; 86(4):383. PubMed ID: 21442646 [No Abstract] [Full Text] [Related]
37. Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure? Kyttaris VC Crit Care Med; 2012 Jan; 40(1):317-8. PubMed ID: 22179358 [No Abstract] [Full Text] [Related]
38. [Treatment of thrombotic thrombocytopenic purpura with rituximab]. Sui T; Yang RC Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):487-8. PubMed ID: 22213874 [No Abstract] [Full Text] [Related]
39. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Robertz J; Andres M; Mansouri Taleghani B; Koneth I; Binet I; Kremer Hovinga JA Am J Hematol; 2019 Oct; 94(10):E259-E261. PubMed ID: 31321811 [No Abstract] [Full Text] [Related]
40. Multiorgan failure and bone marrow necrosis in three adults with sickle cell-β+ -thalassemia. Adamski J; Hanna CA; Reddy VB; Litovsky SH; Evans CA; Marques MB Am J Hematol; 2012 Jun; 87(6):621-4. PubMed ID: 22374850 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]